US · FMC · AGRICULTURAL INPUTS
FMC Corporation (FMC) intrinsic value and stock valuation
$3.89as of 2026-11-21 · Mkt cap 1.35B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
FMC Corporation DCF and intrinsic value
InvestorsCraft values FMC with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from FMC’s statements →
FMC Corporation Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Elevra Lithium Limited (ELVR) $20.62
- Skeena Resources Limited (SKE) $23.83
- Ingevity Corporation (NGVT) $53.75
- Allied Gold Corporation (AAUC) $17.80
- Minerals Technologies Inc. (MTX) $57.97
- USA Rare Earth Inc (USAR) $6.27
- Innospec Inc. (IOSP) $75.56
- The Chemours Company (CC) $10.88
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.47B | $4.25B | $4.49B | $5.8B | $5.05B |
| Operating income | -$-1.89B | $654.7M | $837.9M | $1.29B | $1.17B |
| Net income | -$-2.24B | $339.9M | $1.32B | $736.5M | $739.6M |
| EPSd | -$-17.88M | $2.71M | $10.5M | $5.81M | $5.73M |
| Operating cash flow | -$-80.2M | $671.1M | -$-386.4M | $582.4M | $820.1M |
| Capital expenditure | -$-96.3M | -$-67.9M | -$-133.9M | -$-142.3M | -$-100.1M |
| Free cash flow | -$-176.5M | $603.2M | -$-520.3M | $440.1M | $720M |
| Total assets | $9.69B | $11.7B | $11.9B | $11.2B | $10.7B |
| Total debt | $4.2B | $3.5B | $4.11B | $3.42B | $3.34B |
| Net debt | $3.61B | $3.14B | $3.8B | $2.85B | $2.82B |
| Total equity | $2.1B | $4.51B | $4.43B | $3.4B | $3.14B |
| Cash and short-term investments | $584.5M | $357.3M | $302.4M | $572M | $516.8M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $3.47B | $4.25B | $4.49B | $5.8B | $5.05B |
| Cost of revenue | $2.18B | $2.67B | $2.58B | $3.42B | $2.86B |
| Gross profit | $1.28B | $1.58B | $1.91B | $2.39B | $2.19B |
| Research and development expenses | $266.1M | $278M | $328.8M | $314.2M | $304.7M |
| Selling, general and administrative expenses | $684.9M | $644.6M | $741.6M | $781.7M | $715.4M |
| Other expenses | $2.22B | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating expenses | $3.17B | $922.6M | $1.07B | $1.1B | $1.02B |
| Cost and expenses | $5.35B | $3.59B | $3.65B | $4.51B | $3.88B |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $1.63B | $235.8M | $237.2M | $151.8M | $131.1M |
| Depreciation and amortization | $173.6M | $251M | $251.2M | $166.4M | $160.6M |
| Ebitda | -$-84.7M | $737.4M | $786.2M | $1.3B | $1.19B |
| Operating income | -$-1.89B | $654.7M | $837.9M | $1.29B | $1.17B |
| Total other income/expenses, net | $0.00 | -$-402.2M | -$-537.7M | -$-307M | -$-268.7M |
| Income before tax | -$-1.89B | $252.5M | $300.2M | $983.9M | $897.8M |
| Income tax expense | $352.3M | -$-150.9M | -$-1.12B | $145.2M | $92.5M |
| Net income | -$-2.24B | $339.9M | $1.32B | $736.5M | $739.6M |
| Weighted average shares outstanding | $125.2M | $124.9M | $125.5M | $126M | $128.4M |
| Weighted average diluted shares outstanding | $125.2M | $125.2M | $125.5M | $126.7M | $129.2M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $584.5M | $357.3M | $302.4M | $572M | $516.8M |
| Net receivables | $2.06B | $3.17B | $2.95B | $3.04B | $2.81B |
| Inventory | $1.22B | $1.2B | $1.72B | $1.65B | $1.52B |
| Total current assets | $4.96B | $4.96B | $5.13B | $5.44B | $5.05B |
| Property, plant and equipment, net | $707.4M | $849.7M | $1.01B | $973.4M | $952.2M |
| Goodwill and intangible assets | $2.36B | $3.87B | $4.18B | $4.23B | $4.13B |
| Long-term investments | $100.3M | $25.6M | $19.8M | $14.5M | $9.2M |
| Total non-current assets | $4.73B | $6.7B | $6.8B | $5.73B | $5.62B |
| Total assets | $9.69B | $11.7B | $11.9B | $11.2B | $10.7B |
| Accounts payable | $771M | $768.5M | $602.4M | $1.25B | $1.14B |
| Short-term debt | $1.33B | $361.9M | $958.4M | $562.8M | $464.3M |
| Deferred revenue | $453.1M | $453.8M | $482.1M | $680.5M | $712.7M |
| Total current liabilities | $3.76B | $3.02B | $3.38B | $3.8B | $3.52B |
| Long-term debt | $2.87B | $3.13B | $3.15B | $2.86B | $2.87B |
| Deferred revenue, non-current | $0.00 | $5.5M | $0.00 | $10.1M | $10.3M |
| Total non-current liabilities | $3.83B | $4.13B | $4.11B | $3.97B | $4.01B |
| Capital lease obligations | $97.6M | $130.6M | $147.6M | $150.6M | $163.5M |
| Total liabilities | $7.59B | $7.14B | $7.49B | $7.77B | $7.53B |
| Common stock | $18.6M | $18.6M | $18.6M | $18.6M | $18.6M |
| Retained earnings | $4.17B | $6.64B | $6.59B | $5.56B | $5.09B |
| Accumulated other comprehensive income (loss) | -$-368.7M | -$-410.6M | -$-406.5M | -$-459.6M | -$-325.5M |
| Total equity | $2.1B | $4.51B | $4.43B | $3.4B | $3.14B |
| Total investments | $100.3M | $25.6M | $19.8M | $14.5M | $9.2M |
| Total debt | $4.2B | $3.5B | $4.11B | $3.42B | $3.34B |
| Net debt | $3.61B | $3.14B | $3.8B | $2.85B | $2.82B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | -$-2.2B | $401.7M | $1.42B | $838.7M | $805.3M |
| Depreciation and amortization | $273M | $169.4M | $251.2M | $169.4M | $170.9M |
| Stock-based compensation | $0.00 | $23.8M | $25.9M | $24.2M | $17.8M |
| Change in working capital | -$-602.2M | $233.7M | -$-803.2M | -$-358.1M | -$-111.4M |
| Accounts receivable | $228.4M | -$-348.8M | $192.4M | -$-443.9M | -$-241.1M |
| Inventory | -$-156.3M | $475.8M | -$-72.8M | -$-182.3M | -$-320.7M |
| Accounts payable | $20.1M | $171.7M | -$-626M | $165.3M | $144.4M |
| Net cash provided by operating activities | -$-80.2M | $671.1M | -$-386.4M | $582.4M | $820.1M |
| Investments in property, plant and equipment | -$-96.3M | -$-67.9M | -$-133.9M | -$-142.3M | -$-100.1M |
| Acquisitions, net | -$-23.2M | $335.2M | -$-16.5M | -$-198.2M | -$-5.2M |
| Net cash used for investing activities | -$-108.3M | $263.6M | -$-154.4M | -$-266.4M | -$-112M |
| Common stock issued | $200K | $200K | $5.3M | $9.4M | $7.9M |
| Common stock repurchased | -$-1.8M | -$-2.3M | -$-81.2M | -$-108.9M | -$-408M |
| Dividends paid | -$-291.3M | -$-290.6M | -$-290.5M | -$-267.5M | -$-247.2M |
| Net cash used for financing activities | $394.6M | -$-870.1M | $331.5M | -$-237.4M | -$-747.9M |
| Net change in cash | $227.2M | $54.9M | -$-269.6M | $55.2M | -$-52.1M |
| Cash at end of period | $584.5M | $357.3M | $302.4M | $572M | $516.8M |
| Operating cash flow | -$-80.2M | $671.1M | -$-386.4M | $582.4M | $820.1M |
| Capital expenditure | -$-96.3M | -$-67.9M | -$-133.9M | -$-142.3M | -$-100.1M |
| Free cash flow | -$-176.5M | $603.2M | -$-520.3M | $440.1M | $720M |
Line items
Line items
Line items
About FMC Corporation
FMC Corporation functions as an agricultural science enterprise, delivering products for crop safeguarding, plant wellness, and professional pest and turf management. The company is responsible for creating, commercializing, and selling various crop protection chemicals, including insecticides, herbicides, and fungicides, alongside biologicals, crop nutrition supplements, and seed treatment solutions. These innovations are employed in farming to boost harvest quantity and quality by mitigating diverse insect infestations, weed growth, and plant ailments. Furthermore, its solutions cater to non-agricultural sectors for general pest control. FMC distributes its comprehensive product range through its proprietary sales teams, in collaboration with alliance partners, and via independent distributors and sales representatives. Established in 1883, FMC Corporation is based in Philadelphia, Pennsylvania, and conducts operations across North America, Latin America, Europe, the Middle East, Africa, and Asia.
- CEO
- Pierre R. Brondeau
- Employees
- 5.5K
- Beta
- 0.39
Included in
Explore
Frequently asked questions
What is the intrinsic value of FMC Corporation (FMC)?
FMC Corporation (FMC) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is FMC undervalued?
FMC trades at a price of $3.89 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.